Khandelwal, S.; Boylan, M.; Kirsch, G.; Spallholz, J.E.; Gollahon, L.S.
Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer. Antioxidants 2020, 9, 138.
https://doi.org/10.3390/antiox9020138
AMA Style
Khandelwal S, Boylan M, Kirsch G, Spallholz JE, Gollahon LS.
Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer. Antioxidants. 2020; 9(2):138.
https://doi.org/10.3390/antiox9020138
Chicago/Turabian Style
Khandelwal, Soni, Mallory Boylan, Gilbert Kirsch, Julian E. Spallholz, and Lauren S. Gollahon.
2020. "Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer" Antioxidants 9, no. 2: 138.
https://doi.org/10.3390/antiox9020138
APA Style
Khandelwal, S., Boylan, M., Kirsch, G., Spallholz, J. E., & Gollahon, L. S.
(2020). Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer. Antioxidants, 9(2), 138.
https://doi.org/10.3390/antiox9020138